Tekla Life Sciences Investors HQL
$ 13.87
0.29%
Tekla Life Sciences Investors Balance Sheet 2011-2024 | HQL
Annual Balance Sheet Tekla Life Sciences Investors
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | -1.12 M | -40 | -615 K | -10.1 K | -400 | - | - | - | - |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - |
Total Liabilities |
595 K | 3.33 M | 2.98 M | 1.98 M | 2.66 M | 5.01 M | 800 K | 500 K | 400 K | 1 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - |
Retained Earnings |
127 M | 38.4 M | 142 M | - | - | - | - | - | - | - |
Total Assets |
484 M | 387 M | 478 M | 468 M | 418 M | 468 M | 445 M | 303 M | 228 M | 172 M |
All numbers in USD currency